Author

P. Katsoris

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

G. Kalampounias· 3 shared A. Symeonidis· 2 shared K. Zafeiropoulou· 2 shared S. Alexis· 2 shared A. Varemmenou· 1 shared A.-N. Shaukat· 1 shared C. Aronis· 1 shared D. Anastasopoulos· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

G. Kalampounias

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The ERK1/2-Elk1, JNK-cJun, and JAK-STAT Transcriptional Axes as Potential Bortezomib Resistance Mediators in Prostate Cancer

G. Kalampounias, K. Zafeiropoulou, T. Androutsopoulou, S. Alexis, A. Symeonidis, P. Katsoris

This study identifies upregulated transcription factors in Bortezomib-resistant prostate cancer cells and suggests targeting them to restore sensitivity to proteasome inhibitors.

bioRxiv · Apr 15, 2024Cancer Biology

Recombinant Human TSH Fails to Induce the Proliferation and Migration of Papillary Thyroid Carcinoma Cell Lines

G. Kalampounias, A. Varemmenou, C. Aronis, I. Mamali, A.-N. Shaukat, D. Chartoumpekis, P. Katsoris, M. Michalaki

This study shows that clinically relevant concentrations of recombinant human TSH do not induce proliferation or migration in PTC cell lines, even with TSHR overexpression.

bioRxiv · Apr 2, 2024Cancer Biology

Investigating the mechanisms underlying Bortezomib resistance

K. Zafeiropoulou, G. Kalampounias, S. Alexis, D. Anastasopoulos, A. Symeonidis, P. Katsoris

This study investigates Bortezomib resistance mechanisms in prostate cancer cells, identifying restored proteasome activity, pro-survival pathways, autophagy induction, and reduced reactive oxygen species generation as key factors.

bioRxiv · Jul 29, 2023Cancer Biology